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Background: Dietary creatine has been largely used as an ergogenic aid to improve strength and athletic
performance, especially in short-term and high energy-demanding anaerobic exercise. Recent findings have also
suggested a possible antioxidant role for creatine in muscle tissues during exercise. Here we evaluate the effects of
a 1-week regimen of 20 g/day creatine supplementation on the plasma antioxidant capacity, free and heme iron
content, and uric acid and lipid peroxidation levels of young subjects (23.1 ± 5.8 years old) immediately before and
5 and 60 min after the exhaustive Wingate test.
Results: Maximum anaerobic power was improved by acute creatine supplementation (10.5 %), but it was
accompanied by a 2.4-fold increase in pro-oxidant free iron ions in the plasma. However, potential iron-driven
oxidative insult was adequately counterbalanced by proportional increases in antioxidant ferric-reducing activity in
plasma (FRAP), leading to unaltered lipid peroxidation levels. Interestingly, the FRAP index, found to be highly
dependent on uric acid levels in the placebo group, also had an additional contribution from other circulating
metabolites in creatine-fed subjects.
Conclusions: Our data suggest that acute creatine supplementation improved the anaerobic performance of
athletes and limited short-term oxidative insults, since creatine-induced iron overload was efficiently circumvented
by acquired FRAP capacity attributed to: overproduction of uric acid in energy-depleted muscles (as an end-
product of purine metabolism and a powerful iron chelating agent) and inherent antioxidant activity of creatine.
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Creatine is a glycine-arginine metabolite synthesized in
the liver, pancreas, and kidneys and is naturally stored
by skeletal and cardiac muscles as an energy supplier in
the phosphocreatine form [1]. Muscle phosphocreatine
plays a key role in anaerobic ATP production in muscles
via the highly exergonic reaction catalyzed by creatine
kinase. Thus, creatine monohydrate has become an in-
creasingly popular dietary supplement, particularly for
improvement of explosive strength performances [2,3].
Recent findings have also proposed that creatine* Correspondence: tacitojr@ufpr.br
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reproduction in any medium, provided the orsupplementation could efficiently restrain oxidative
processes in vitro [4,5]. At least two antioxidant
mechanisms are currently suggested for creatine: (i) dir-
ect scavenging of hydroxyl (HO•) and nitrogen dioxide
(NO2• ) radicals [6–8] by the creatine N-methylguanidino
moiety; and (ii) lasting use of anaerobic energy-supplying
pathways because of accumulated creatine and preserved
glycogen in skeletal muscles [9–11].
A plethora of data has revealed that reactive oxygen
species (ROS) are overproduced during and after
anaerobic/resistance exercise, but from cellular sources
other than mitochondria [12,13]. Induced by an apparent
ischemia-reperfusion process during intense contractile
activity of the resistance exercise, accumulating concen-
trations of AMP in exhausting muscle fibers activate thetd .This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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purine catabolic pathway – which catalyzes the conver-
sion of hypoxanthine into uric acid with concomitant
overproduction of superoxide radicals (O2•
-) and hydro-
gen peroxide (H2O2) [14]. In turn, O2•
- and H2O2 are
closely related to the production of the highly reactive
hydroxyl radical (HO•) by iron-catalyzed reactions (Eqs. 1
and 2) that harmfully initiate oxidizing processes in cells,
such as lipoperoxidation [15].
Fe3þ aq:ð Þ þO2 aq:ð Þ ! Fe2þ aq:ð Þ þO2 gð Þ ð1Þ
Fe2þ aq:ð Þ þH2O2 aq:ð Þ ! Fe3þ aq:ð Þ þOH aq:ð Þ þHO aqð Þ
ð2Þ
Although some information linking iron metabolism
and oxidative stress in exercise/sports is currently avail-
able, data reporting changes in iron homeostasis of
plasma during/after one single bout of exercise com-
pared to antioxidant responses are still scarce. Sources
of iron overload in plasma during/after exercise are also
unclear. Noteworthy, many authors have reported
evidence of a “sport anemia” syndrome in athletes and
experimental animals – especially in females – as a
result of chronic iron deficiency imposed by prolonged
training periods [16,17]. Thus, based on iron-redox
chemistry, progressive ROS overproduction could be
triggered by iron overload in plasma and extracellular
fluids during/after anaerobic exercise [18,19]. Together,
these redox changes have been increasingly associated to
lower athletic performance, early fatigue, inflammatory
processes, and higher risks of post-exercise injuries [20–
22].
Thus, this work aims to study the influence of acute
creatine supplementation on anaerobic performance and
redox status in the plasma of physically active young
subjects submitted to the exhaustive Wingate test.
Because iron homeostasis is a key factor in triggering
oxidative stress, our study monitored total and heme
iron release in plasma, ferric-reducing capacity in plasma
(FRAP assay), and uric acid and lipid oxidation in
plasma immediately before as well as 5 and 60 min after
the Wingate test. The novelty of the study relies on the
selected redox parameters, which refer to pivotal check-
points of redox imbalances provoked by the anaerobic
exercise.
Materials and methods
Standards and reagents
Folin-Ciocalteau reagent, bovine serum albumin (BSA),
sodium potassium tartarate, butylated hydroxytoluene
(BHT), thiobarbituric acid (TBA), ethylenediamine tetra-
acetic acid (EDTA) and Triton X-100 were purchased
from Sigma–Aldrich (St. Louis, MO, USA). Solvents forchromatography analysis were purchased from Merck
(Düsseldorf, Germany). Copper (II) sulphate pentahy-
drated was obtained from Vetec Química Fina Ltda (Rio
de Janeiro, Brazil). All the reagents were of analytical
grade and the stock solutions and buffers prepared with
Milli-Q (Millipore) purified water. Biochemical kits for
plasma/serum heminic-‘free’ iron determinations were
purchased from Doles Reagentes e Equipamentos para
Laboratórios Ltda (Goiania, Brazil). The kit for uric acid
determination was from BioClin Quibasa Ltda (Belo
Horizonte, Brazil).
Subjects
Sixteen male subjects undergraduation students (age,
23.1 ± 5.8 years; height, 175.4 ± 2.3 cm; weight,
81.1 ± 9.3 kg), were invited to participate in the study.
All subjects were experienced in cycling activity and
were physically active for the last 6 months before the
study (at least three times a week). Subjects were
randomly split into two groups: placebo- or creatine-
supplemented groups. The exercise protocol and all
other experimental procedures were approved by the
Ethics Committee of School of Physical Education and
Sport, University of Sao Paulo, which conforms with the
Standards for Research Using Human Subjects,
Resolution 196/96 of the USA National Health Council
of 10/10/1996 and all consented in writing to the
achievement of experimental procedures (physical effort
undertaken, sample collection, etc.). The subjects partici-
pating in this work attested no use of drugs prohibited
by the International Olympic Committee (IOC). In
addition, all subjects were not under any systemic or
topical medical treatment/therapy for, at least, 60 days
before the Wingate test (not even using anti-inflamma-
tory drugs), and had no history of smoking, alcohol use,
obesity or systemic disease.
Creatine supplementation
Creatine group subjects were supplemented five times/
day with 4 g creatine monohydrate for a total dosage of
20 g creatine/day for 1 week (dissolved in 500 mL of
drinking water). Placebo subjects followed the same
supplementation protocol but with 4 g maltodextrin/
dose (double-blind study). After 7 days, five athletes
(three from the creatine group and two from the placebo
group) reported slight gastrointestinal discomfort and
decided to leave the study.
Wingate protocol
The Wingate Test [23] was performed using a leg
ergometer (Cybex cycle ergometer; Model Metabolic
Systems; Division of Lumex, Ronkonkoma, NY, USA) at
the Center for Studies in Exercise Physiology (CEFE) at
the Federal University of São Paulo (UNIFESP). In this
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thoroughly used for male athletes. Volunteers performed
a warm-up set of 5 min in the cycle ergometer (25 W)
with three sprints of 6 s every minute, followed by a 2-
min break before the test. This familiarization test is im-
portant to avoid artifacts during the second Wingate test
(after supplementation). Each trial was strongly encour-
aged by the evaluator to achieve maximum possible
effort, without raising the trunk from the bicycle seat
during the test. After each set of maximal effort, the
workload was adjusted to accommodate an active
recovery mode (no resistance, 80 rpm, for 3 min).
Volunteers were instructed not to perform vigorous
physical activity and to avoid drinking caffeinated
substances (coffee, chocolate, mate, guarana, energy
drinks, and cola) or alcohol within 24 h prior to the
tests.
Blood sampling and plasma preparation
Blood samples (5 mL) were withdrawn from the forearm
cubital vein of the volunteers immediately before (t0), as
well as 5 min (t5) and 60 min after (t60) the Wingate
test, using EDTA-containing Vacutainer kits. Samples
were stored in a freezer at −80 °C until analysis. All
materials used for blood collection (including syringes,
needles, and bottles) were disposable and handled by
medical professionals of the CEFE/UNIFESP to prevent
potential physical complications.
Iron content in plasma
Iron concentration in plasma was assayed with a specific
biochemical kit from Doles-Bioquímica Clínica (Brazil),
using the method first described by Goodwin et al [24].
Currently the method is based on the ferrozine detection
(at 560 nm) of ferrous ion released from plasma trans-
ferrin by the reducing agent FerrozineW, which contains:
0.36 M hydroxylamine chloride, 0.10 M glycine, 14 mM
thiosemicarbazide, and 0.50 mM octylphenoxypolyetox-
yethanol, at pH 2.2 [25]. Total iron released in plasma
was calculated by determining the area under curves
within the time-span of t0 and t60 (AUCt0-t60).
Ferric-reducing activity in plasma (FRAP)
The ferric-reducing activity in plasma (FRAP) assay was
performed as previously described by Benzie & Strain
[26] but replacing the iron (II) chelating agent 2,4,6-tri-
pyridyl-S-triazine (TPTZ) by its analog 2,3-bis(2-pyri-
dyl)-pyrazine (DPP) [27]. Control analytical assays with
standard ferrous and ferric ions [Fe(II) and Fe(III),
respectively] revealed accurate stoichiometric equiva-
lence between the two chelating agents (data not
shown). Briefly, the reactant mixture for FRAP assay
contains 10 mM DPP (stock solution prepared in
40 mM HCl) and 20 mM FeCl3 in 0.30 M acetate buffer(pH 3.6). To 300 μL of FRAP reactant mixture, 10–20
μL sample is added together with 40–30 μL distilled
water (total volume, 350 μL). Absorbance at 593 nm was
recorded for 4 min in a microplate reader TECAN (Salz-
burg, Austria) to determine the rate of Fe(II)-DPP
complex formation as compared to a Fe(II) standard
curve. Total FRAP was calculated by determining the
area under curves within the time-span of t0 and t60
(AUCt0-t60).
Total heme-iron content in plasma
Heme-iron content in plasma was assayed with a specific
biochemical kit from Doles-Bioquímica Clínica (Brazil).
The method is based on the heme-iron oxidation by the
ferricyanide anion contained in a solution with 0.10 M
potassium dihydrogenophosphate, 60 mM K3[Fe(CN)6],
77 mM KCN and 82 mM Triton X-100). Total heme-
iron cyanide – which includes heme groups from
hemoglobin, myoglobin, and other hemeproteins – is
stoichiometrically detected at 540 nm [28,29]. Total
heme-iron released in plasma was calculated by deter-
mining the area under curves within the time-span of t0
and t60 (AUCt0-t60).
Uric acid determination
Plasma uric acid content was assayed with a biochemical
kit from BioClin-Quibasa (Belo Horizonte, Brazil). In the
assay mixture, H2O2 produced from uric acid in the
presence of uricase (to form allantoin) is coupled with
p-hydroxybenzoate and 4-aminoantipyrine oxidation
catalyzed by peroxidase to form a pinkish chromophore
detected at λ= 505 nm [30]. Total uric acid released in
plasma was calculated by determining the area under
curves within the time-span of t0 and t60 (AUCt0-t60).
Furthermore, total uric acid released in plasma within
the t0 – t60 interval was correlated with total FRAP, but
comparison was purposely made with following groups:
(i) subject samples not affected by creatine: pre-placebo,
post-placebo, and pre-creatine together; and (ii) post-
creatine samples.
Lipid peroxidation measurements
One of the most frequently evaluated byproducts from
lipid peroxidation is malondialdehyde (MDA), which
was accurately analyzed here by chromatographic HPLC
technique [31]. The biomarker MDA was first dispersed
from cellular compartments in a mixture of 50 μL of
plasma with 250 μL methanol 30 % for 15 min (4o C) in
an ultrasound bath. Afterwards, 100 μL of 0.50 %
butylated hydroxytoluene (BHT) were added to the
samples to avoid oxidation reactions in the following
steps. Molecules of MDA were then converted into a
pinkish chromophore by derivatization with 600 μL of a
0.4 % thiobarbituric acid solution (TBA, in 0.20 M HCl)
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was then filtered (MilliPore nylon membranes, 0.45 μm
pore size, 13 mm diameter) and injected (20 μL) in a
Shimadzu SCL10A HPLC system provided with
LC10AD pumps and fluorescence (RF-10AXL) detector.
The MDA-TBA adduct was isocratically eluted by the
65:35 mixture of 25 mM phosphate buffer (pH 6.5) and
methanol 30 % through a 0.39 x 30 cm μBondapack C18
column (retention time ~ 6 min) and detected by fluores-
cence (excitation λ= 515 nm; emission λ= 555 nm).
Total areas of MDA peaks of samples were compared
with a standard curve obtained with 1,1,2,2-tetraethoxy-
propane (also in methanol 30 %). Total MDA released in
plasma was calculated by determining the area under
curves within the time-span of t0 and t60 (AUCt0-t60).
Statistical analysis
All data were analyzed using a 2x2 Factorial (two-way)
ANOVA for creatine supplementation and pre-/post
variations followed by a post hoc Tukey test to investi-
gate possible interactions between groups (statistical tool
VassarStats, on March 7th, 2012, available online at:
http://faculty.vassar.edu/lowry/anova2u.html). Results
were expressed as mean± SEM of, at least, triplicates of
experiments.
Results
After supplementation but before the anaerobic test
(Wpost; section 2.4), creatine-fed subjects showed a
significant 2.4-fold increase in plasmatic iron (t0post/
t0pre; p< 0.005), heme iron (80 %; p< 0.05), and FRAP
(3-fold; p< 0.05) compared with t0pre scores, while the
placebo group showed no significant change (Table 1).
These results were interpreted as the subjects’ basal
levels because they were obtained from blood samples
collected before the exhaustive Wingate test (t0pre andTable 1 Redox biomarkers of anaerobic exercise in
plasma of subjects before (t0pre) and after 20 g/day
creatine monophosphate supplementation for 1 week
(t0post)
Placebo Creatine
t0pre
(a) t0post
(b) t0pre
(c) t0post
(d)
Iron content
(μg/dL)
33.3 ± 7.8
(}c;*d)
26.3 ± 5.5
(*c)
12.2 ± 3.4
(}a;*b,d)
23.7 ± 1.8
(*a,c)
Heme-iron
(mg/mL)
7.94 ± 0.43
(*c)
7.89 ± 0.24
(*c)
4.77 ± 0.93
(*a,b,d)
6.47 ± 0.13
(*c)
FRAP
(μmolFe2+
/min/mL)
0.057± 0.011
(}c,d)
0.077 ± 0.020
(}d;*c)
0.110 ± 0.014
(}a,d;*b)
0.300 ± 0.038
(}a,b,c)
MDA
(μmol/L)
0.129± 0.023 0.148 ± 0.043 0.186 ± 0.050 0.129 ± 0.025
Uric acid
(mg/mL)
1.62 ± 0.94
(}c,d)
1.62 ± 0.75
(}c,d)
2.93 ± 0.49
(}a,b)
3.44 ± 0.39
(}a,b)
(}) p< 0.005; (#) p< 0.01; (*) p< 0.05.t0post); thus, they were not related to the oxidative stress
imposed by anaerobic exercise. On the other hand, two-
way ANOVA test followed by post hoc Tukey’s analysis
revealed moderate heterogeneity between group placebo
and creatine-fed before the exhaustive Wingate test
(Table 1) for all redox parameters analysed, except lipid
peroxidation (MDA measurements). Nevertheless, all
values found in groups before the Wingate test (t0pre for
both placebo and creatine-fed groups; Table 1) were
within the regular range in plasma of human subjects
and, thus, could reflect the natural variations expected
for human populations. Biochemical changes in the
iron-related parameters were observed together with
28 % lower levels of lipid oxidation (t0post/t0pre; Pear-
son’s r< 0.01), whereas the placebo group was unaltered.
Conversely, no change in the total uric acid content in
plasma was observed in t0post/t0pre ratios from placebo
and creatine groups (Table 1). Weight and percent body
fat were also unaltered after acute creatine supplementa-
tion (data not shown).
Regarding performance in the Wingate test (Table 2),
neither anaerobic capacity (AnC; p = 0.1275) nor total
workload (TotalWL; p = 0.1040) were significantly
altered by creatine supplementation, whereas maximum
anaerobic power was significantly increased by 10.5 %
(AnPpeak; p = 0.0029) and the fatigue index showed a
strong trend for anaerobic effort reduction upon creatine
supplementation (p = 0.0890). The fatigue index was not
determined in the placebo group. Discrepancies between
Wpre of placebo and creatine (basal values in Table 2)
were identified herewith by the two-way ANOVA test,
but we assumed that such heterogeneity would not
represent a relevant factor in explaining major changes
in redox/metabolic parameters or anaerobic perform-
ance indexes.
Total releases of iron, heme iron, FRAP, MDA, and
uric acid plasma by the Wingate test were calculatedTable 2 Indexes of anaerobic performance of subjects
during a Wingate protocol before (Wpre) and after (Wpost)
20 g/day creatine monophosphate supplementation for
1 week (double-blind study; MEAN±SEM)
Placebo Creatine
Wpre
(a) Wpost
(b) Wpre
(c) Wpost
(d)
AnPpeak
(W/kg)
9.68 ± 1.08
(*c,d)
10.33 ± 0.80
(*d)
11.4 ± 0.5
(*a,d)
12.6 ± 0.6
(*a,b,c)
AnC
(W/kg)
5.05 ± 0.52
(#c,d)
5.08 ± 0.35
(#c,d)
8.1 ± 0.4
(#a,b)
8.5 ± 0.8
(#a,b)
TotalWL
(J/kg)
151.8 ± 15.8
(#c,d)
152.3 ± 10.5
(#c,d)
241.1 ± 12.4
(#a,b)
255.0 ± 21.2
(#a,b)
Fatigue
index
(%)
n.d. n.d. 60 ± 8 40 ± 8
(}) p< 0.005; (#) p< 0.01; (*) p< 0.05.
n.d. = not determined.
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Figure 1 Total iron released in plasma from t0 (immediately before the Wingate test) until t60 (60 min after). (A) Individual pre-/post-
variation with placebo or creatine supplementation; (B) Average pre-/post-variation with placebo or creatine supplementation.
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pre- and post-placebo versus pre- and post-creatine
scores. Figure 1A shows the pre/post variation of total
iron released within the t0–t60 interval in both placebo
and creatine groups. All creatine-fed subjects demon-
strated higher loads of released iron with exercise after
supplementation (2.4-fold higher; p< 0.001), whereas
the placebo did not vary (Figure 1B). Noteworthy, the
heterogeneity of basal iron content in plasma of placebo-
and creatine-fed subjects was also reflected in observed
discrepancies between groups when evaluating total iron
content in plasma within the t0-t60 interval (Pearson’s
r< 0.05, not shown in Figure 1A).
Total released heme iron in the creatine group did not
increase as abruptly as the total iron content, but the
post/pre variation was still significantly higher (17 %;
p< 0.05; Figure 2A and B). The placebo group was un-
altered regarding post/pre variation.0
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Figure 2 Total heme-iron released in plasma from t0 (immediately be
post-variation with placebo or creatine supplementation; (B) Average pre-/As an antioxidant response against the observed
massive amount of iron ions released during (Wingate)
exercise, total FRAP in creatine-fed individuals also
increased by almost 3-fold in the post/pre comparison
(Figure 3B; p< 0.01). Moreover, the heterogeneity of
basal FRAP capacity of placebo- and creatine-fed sub-
jects was reproduced when total FRAP capacity was
measured in subjects within the t0-t60 interval
(Pearson’s r< 0.05, not shown in Figure 3A). We
assumed that none of the basal variations found for
iron-related redox parameters could drastically interfere
in the proposed antioxidant action of creatine (or one of
its metabolites) following the exhaustive Wingate test,
since all these values were within the regular range of
human populations.
In contrast to the diminished scores observed in
t0 samples of creatine-fed individuals (Table 1), no
significant change was observed between placebo0,0
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Figure 3 Ferric-reducing activity in plasma (FRAP) from t0 (immediately before the Wingate test) until t60 (60 min after). (A) Individual
pre-/post-variation with placebo or creatine supplementation; (B) Average pre-/post-variation with placebo or creatine supplementation.
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released in plasma within the t0–t60 interval
(Figure 4A-B).
Finally, acute creatine supplementation resulted in a
significant post/pre increase of 20 % (p< 0.05) in the
uric acid released in plasma within the t0–t60 interval,
whereas the placebo group did not vary significantly
(Figure 5A and B).
Interestingly, the total uric acid released in plasma
within the t0–t60 interval (Wingate test) was very well
correlated with the total FRAP released, both in subjects
supplemented with creatine (R = 0.980; black triangles;
Figure 6) or without creatine (R = 0.788, here purposely
grouped as pre-placebo, post-placebo, and pre-creatine;
open circles; Figure 6). However, upon creatine0
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is less dependent on total uric acid than in samples that
lack the creatine effect (namely pre-placebo, post-pla-
cebo, and pre-creatine samples). Linear regression equa-
tions for post-creatine and grouped pre-placebo, post-
placebo, and pre-creatine samples were as follows, re-
spectively: (i) (Total Uric Acid) = 84.8 + 7.01(Total
FRAP), R = 0.980; and (ii) (Total Uric Acid) = 43.2 + 16.61
(Total FRAP); R = 0.788 (insets, Figure 6).
Discussion
Creatine has long been credited as an efficient ergogenic
supplement that improves the anaerobic power of ath-
letes submitted to high-intensity, short-duration tests
[1,3]. The metabolic strategy is supported by the0,0
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Figure 5 Uric acid content plasma (MDA) from t0 (immediately before the Wingate test) until t60 (60 min after). (A) Individual pre-/post-
variation with placebo or creatine supplementation; (B) Average pre-/post-variation with placebo or creatine supplementation.
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type-II) and enhancement of ATP generation for extra
power output during early/anaerobic stages of exercise.
The maximum anaerobic power was significantly
increased by 10.5 % after acute 20 g/day creatine supple-
mentation (Table 2), together with strong tendencies for
increased total workload and reduced fatigue index, al-
though not significant in the present study. However,
creatine has also been shown to have a role as an anti-
oxidant compound that hampers overproduction of0 5 10
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supplementation (postCRE) were compared to samples collected from plac
postPLA, respectively) and from subjects before creatine supplementation (harmful reactive oxygen species (ROS) within contractile
skeletal muscles during exercise [6,32]. This hypothesis
is in line with recent findings by Sestili et al. [33] who
demonstrated that creatine treatment can directly
prevent cell death in C2C12 myoblasts due to its
antioxidant activity. Regarding mechanisms, due to its
substantial absorption and dose-dependent accumulation
in plasma following supplementation [34], creatine is
supposed to exert a direct scavenging effect against ROS
produced in plasma – with concomitant minor chelating15 20 25 30
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Parameter Value Error
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A           84,84 18,08
B           7,01 0,82
-----------------------------------------------
R SD N P
-----------------------------------------------
0,980 9,29 5 3,31E-3
prePLA + postPLA + preCRE
postCRE
[0-60 min]
ic acid content and ferric-reducing activity in plasma (FRAP) of
ingate test. Samples collected in subjects after creatine
ebo group (both before and after supplementation, prePLA, and
preCRE).
Barros et al. Journal of the International Society of Sports Nutrition 2012, 9:25 Page 8 of 10
http://www.jissn.com/content/9/1/25action [7] – that enhanced blood antioxidant capacity in
creatine-fed subjects (FRAP, Table 1). Neither creatine
itself nor any of its metabolites (e.g. creatinine) were dir-
ectly measured here. Therefore, we cannot exclude the
hypothesis of a co-adjutant chelating role of one of the
creatine metabolites in plasma following its acute sup-
plementation. Further studies are necessary to better ad-
dress this hypothesis.
Iron ions are reportedly released in plasma during/
after strenuous exercise, but intracellular or plasmatic
sources are still relatively obscure [18,19]. Regarding
total iron released in plasma (AUCt0-t60), creatine sup-
plementation resulted in higher amounts released dur-
ing/after 60 min of the exhaustive Wingate test (2.4-fold
higher; Figure 1A and B). However, the same 2.4-fold
higher iron content was also observed in creatine-fed
subjects at rest, with lower increment from heme-iron
(t0post/t0pre, Table 1). Thus, it is tempting to suggest that
the pre-acquired increased iron content in plasma dur-
ing the creatine supplementation period was responsible
for a similar increase during/after exercise, indicating
that no other source was mainly contributing to the total
iron load in plasma during exercise. Accordingly, heme
iron clearly provided a minor contribution (20 %) to the
observed massive iron release in plasma during/after ex-
haustive exercise in creatine-fed subjects tested in the
present study (Figure 2A-B). Based on the presented
data, hemolysis and rhabdomyolysis are processes pos-
sibly less related to iron release in the plasma of placebo
subjects during/after Wingate test. These data are in
agreement with new findings that suggest ferritin and,
perhaps, transferrin are the major free iron sources that
trigger oxidative stress during exercise [35]. Notably, free
iron actually refers to metal ions bound to low-molecu-
lar-weight metabolites in biological fluids (such as ascor-
bate, adenosine, and citrate) that can still catalyze the
Fenton-reaction [36], a natural chemical process that
produces one of the most aggressive ROS, the hydroxyl
radical (HO•). Early studies have shown that alterations
in the extent of iron storage in tissue ferritins (rat liver
and spleen) in vivo coincide with experimentally induced
alterations in oxidative metabolism within cells: e.g. aer-
obic conditions (or experimental procedures) leading to
ATP synthesis will favor the movement of serum iron to
liver and spleen ferritins, whereas tissue hypoxia leading
to ATP degradation will favor the release of ferritin iron
to the serum and will inhibit the movement of serum
iron to tissue ferritin [37]. Despite of that, none of these
experimental conditions included strenuous aerobic or
anaerobic exercises. Furthermore, in vitro assays demon-
strated that the xanthine oxidase system plays an im-
portant role in the process of iron reduction (ferric to
ferrous ions) and release from hepatic ferritin in
hemorrhagic shock animals [38].Vigorous contractions during high-energy-demanding
anaerobic exercises activate O2-consuming xanthine oxi-
dase (XO) at local vascular endothelium [39]. In
exhausting fast-twitch fibers (when ATP supply is lim-
ited), accumulation and subsequent deamination of
AMP enhance inosine conversion to hypoxanthine.
Under these circumstances, accumulated hypoxanthine
is efficiently oxidized by pre-activated XO to xanthine,
and ultimately to uric acid, which also renders high pro-
duction of O2•
-, H2O2, and other ROS [40,41]. Thus, uric
acid content in plasma is related to intracellular energy
balances in muscle fibers, and thus performance, be-
cause the degree of adenine catabolism is regulated by
[ATP]:[AMP] ratios [42]. Accordingly, subjects supple-
mented with creatine showed approximately 20 % higher
total uric acid released in plasma than the placebo group
(Figure 5A and B), which is also slightly related to the
10.5 % higher scores of maximum anaerobic perform-
ance (Table 2). Xanthine oxidase-based ROS overpro-
duction could culminate in harsh oxidative insult to
muscle fibers, unless efficient antioxidant systems are
promptly activated. This condition is particularly
enhanced by the massive release of Fenton-catalytic iron
metals during/after exhaustive exercise [18,19]. Inde-
pendently, with a subcellular or extracellular source of
iron overload, all individuals displayed adequate plasma
antioxidant responses as suggested by the observed pro-
portional increases in ferric-reducing activities in plasma
during/after exercise (FRAP; Figure 3A and B) and by un-
altered levels of lipid oxidation until 60 min after the Win-
gate test (Figure 4A-B). Moreover, the iron content in
plasma and FRAP were also augmented in creatine-supple-
mented subjects at rest (t0post/t0pre in Table 1), whereas
28 % lower levels of lipid oxidation were also found in
plasma (Table 1). Taken together, these facts corroborate
the hypothesis of how tightly iron homeostasis is con-
trolled in animals and humans possibly to prevent metal-
catalyzed formation of aggressive ROS such as HO• radical.
Uric acid, the final product of purine catabolism, has
been proven to be an efficient antioxidant and chelating
agent for iron ions [43]. Furthermore, uric acid alters the
redox potential of chelated Fe2+/3+ and, thus, seems to
act as an antioxidant by preventing Fenton-like reactions
in many biological systems and the oxidation of other
antioxidant systems, such as ascorbate [36]. Interest-
ingly, addition of uric acid to the culture media (at non-
physiological concentrations) limited polyunsaturated
fatty acid oxidation in the erythrocyte membrane and
prevented hemolysis in vitro [44] similarly as proposed
in the present study by the observed lower heme iron re-
lease (Figure 2A-B). As the missing part of the puzzle,
uric acid is apparently one of the major contributors for
the FRAP antioxidant response during/after anaerobic
exercise, as strong linear correlations between FRAP and
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petition horses (Pearson’s r = 0.78) [45,46]. This concept
is fully consistent with our data presented in Figure 6.
With regard to total amounts released in plasma
during/after the Wingate test (UACt0-t60), uric acid
and FRAP were very well correlated in both placebo
and creatine groups (Figure 6). However, notably,
higher FRAP scores found in creatine-fed subjects is
less dependent on total uric acid than in samples that
lack the creatine effect (namely pre-placebo, post-
placebo and pre-creatine). This suggests that an additional
chelating (and Fe2+/3+ redox-inactivating) agent is present
in the plasma of creatine-fed subjects during/after anaer-
obic exercise to provide an extra antioxidant role, and the
best candidate is creatine itself. Even considering the well-
described antioxidant activity of creatine in vitro and
in vivo [6,7], whether such an antioxidant/chelating role is
actually performed by creatine, or any of its metabolites
(e.g., creatinine), remains unclear and further studies are
necessary.
Conclusions
Our data are consistent with the hypothesis that creatine
supplementation rebalances iron homeostasis both at rest
and during/after anaerobic exercise. Such a risky condi-
tion concerning ROS production and oxidative stress is
circumvented by a proportional increase in FRAP pro-
vided by uric acid and by creatine itself (or its metabolites)
in plasma. Under these circumstances, lipid oxidation
scores were unaltered after the exhaustive Wingate test.
Although acute supplementation of creatine only resulted
in modest improvement of anaerobic capacity (an attempt
to minimize adverse renal dysfunctions of its chronic use),
it also provided an additional antioxidant protection in
plasma of supplemented subjects. Unfortunately, it is not
well stated that the improved antioxidant capacity of
plasma will result in better anaerobic performance, but
general health benefits are truthfully suggested here, for
example in restraining post-exercise inflammatory pro-
cesses. Anaerobic exercise to exhaustion reveals an intri-
cate redox mechanism, which is vigorously orchestrated
by iron release and FRAP responses, with uric acid as the
main protagonist. Creatine herewith is an uprising actor
stealing the scene in our new adaptation of the story.
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